“Rising Emphasis on ACTs and Community-Based Access Models”
- A significant and accelerating trend in the Africa malaria treatment market is the growing adoption of artemisinin-based combination therapies (ACTs) as the preferred frontline treatment for Plasmodium falciparum infections. This is driven by strong endorsement from the World Health Organization (WHO) and large-scale support from global health organizations such as the Global Fund and UNICEF
- For instance, Coartem (by Novartis) is one of the most widely distributed ACTs across African countries through national health programs and donor-funded initiatives, offering a reliable and effective solution to combat malaria
- Community-based healthcare delivery has emerged as a key component in expanding access to treatment in rural and underserved areas. Through the deployment of trained community health workers, early diagnosis and treatment with ACTs are made more accessible, reducing the risk of complications and transmission
- In addition, partnerships between governments, NGOs, and regional pharmaceutical manufacturers are strengthening the availability and affordability of antimalarial medications, with countries such as Nigeria and Kenya scaling up local production capabilities
- This trend toward prioritizing ACT accessibility, combined with decentralized treatment delivery and stronger public health frameworks, is transforming malaria care in Africa. The approach aligns with broader health system goals of reducing disease burden, improving health equity, and achieving universal access to essential treatments
